ClinConnect ClinConnect Logo
Search / Trial NCT06748716

Effect of Blue Light Blocking on Reducing Manic Symptoms in Bipolar Disorder

Launched by RAYAN NASSERDINE · Dec 18, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at whether wearing special orange glasses that block blue light can help reduce manic symptoms in people with Bipolar Disorder (BD). Participants in the study will be adults aged 18 to 70 who are currently hospitalized due to manic episodes. They will be randomly assigned to either wear the blue-light blocking glasses or regular clear glasses (which won’t provide any special treatment) for 10 days, along with their usual medication. The researchers want to see if the orange glasses can lead to a greater improvement in mood and behavior, as measured by a specific rating scale.

If you or a loved one is considering participation, it’s important to know that this study is focused on individuals who are currently experiencing manic symptoms and meet certain criteria. Those who have severe eye problems, are going through withdrawal from drugs or alcohol, or have previously used blue-light blocking glasses will not be eligible. The study is designed to gather important information while ensuring that participants' rights and privacy are respected.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients hospitalized with manic symptoms in HUG
  • Diagnostic of Bipolar Disorder according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria
  • aged 18-70 years
  • Exclusion Criteria:
  • previous knowledge of blue-blocking glasses
  • not consenting to participate
  • severe eye disease or traumatic injury affecting both eyes.
  • withdrawal symptoms from any drug or alcohol at the time of admission (the start of the intervention will be delayed until withdrawal symptoms have ceased)

About Rayan Nasserdine

Rayan Nasserdine is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through rigorous clinical studies. With a focus on innovative therapies and a patient-centered approach, Rayan Nasserdine collaborates with leading healthcare professionals and research institutions to ensure the highest standards of scientific integrity and ethical conduct. By fostering a culture of collaboration and transparency, the organization aims to accelerate the development of groundbreaking treatments across various therapeutic areas, ultimately enhancing the quality of care for patients worldwide.

Locations

Genève, Suisse, Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported